A Pharmacist-led Transitions of Care Program

September 18, 2020 updated by: Chiahung Chou, Ph.D., Auburn University

The Impact of a Pharmacist-Led Transitional Care Program on Health Outcomes of Uninsured Populations

This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized that a pharmacist-led transitions of care program will reduce 30-day hospital readmission rates among the uninsured discharged from a community hospital.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Auburn, Alabama, United States, 36830
        • Mercy Medical Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 years old or older
  • Uninsured
  • English speaking
  • Discharged from East Alabama Medical Center within the past 16 days

Exclusion Criteria:

  • Patients who did not show up for the first follow-up visit with the study pharmacist after being referred by the care coordinator at East Alabama Medical Center

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transitions of care
The study participants in this aim received usual care plus medication reconciliation, daily schedule for medication taking and medical condition monitoring, and follow-up phone calls from a pharmacist.
The intervention was a pharmacist-led transitions of care program that include medication reconciliation, daily schedule for medication taking and medical condition monitoring, and follow-up phone calls from a pharmacist at 60- and 90-day post-discharge in addition to the usual care.
No Intervention: Usual care
The study participants in this arm received usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day hospital readmission
Time Frame: 30-day post-discharge
Whether a study participant had any hospital readmission 30-day post-discharge
30-day post-discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
60-day hospital readmission
Time Frame: 60-day post-discharge
Whether a study participant had any hospital readmission 60-day post-discharge
60-day post-discharge
90-day hospital readmission
Time Frame: 90-day post-discharge
Whether a study participant had any hospital readmission 90-day post-discharge
90-day post-discharge
30-day emergency department (ED) visit
Time Frame: 30-day post-discharge
Number of ED visits among study participants in each study arm 30-day post-discharge
30-day post-discharge
60-day emergency department (ED) visit
Time Frame: 60-day post-discharge
Number of ED visits among study participants in each study arm 60-day post-discharge
60-day post-discharge
90-day emergency department (ED) visit
Time Frame: 90-day post-discharge
Number of ED visits among study participants in each study arm 90-day post-discharge
90-day post-discharge
30-day follow-up visit with a primary care provider
Time Frame: 30-day post-discharge
Did a study participant keep a follow-up appointment with a primary care provider
30-day post-discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chiahung Chou, PhD, Auburn University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2018

Primary Completion (Actual)

July 16, 2019

Study Completion (Actual)

July 16, 2019

Study Registration Dates

First Submitted

September 15, 2020

First Submitted That Met QC Criteria

September 18, 2020

First Posted (Actual)

September 21, 2020

Study Record Updates

Last Update Posted (Actual)

September 21, 2020

Last Update Submitted That Met QC Criteria

September 18, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 18-342 EX 1809

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

Clinical Trials on Transitions of care

Subscribe